Therapeutic Applications of Immunobiologics in Autoimmune and Inflammatory Diseases
Kannan Badri Narayanan · 2026
Read Therapeutic Applications of Immunobiologics in Autoimmune and Inflammatory Diseases by Kannan Badri Narayanan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13516269.txt.
Description
Kannan Badri Narayanan reviews, in a 2026 article, biologic medicines for autoimmune and inflammatory disease. These engineered proteins aim at single immune pathways, a sharper approach than broad immune suppression. The tour covers drugs that block T-cell activation, deplete or divert immune cells, and neutralise inflammatory messengers such as tumour necrosis factor and a string of interleukins. B-cell and IgE-directed agents complete the arsenal.
Trial and real-world evidence shows deep impact across rheumatoid arthritis, psoriasis, lupus, bowel inflammation, asthma, and more. How tightly a drug binds its target and what it does downstream decide much of its effect. Safety watching stays essential, since immune reactions, opportunistic infections, and manufacturing variation all pose risks. Cheaper biosimilars promise wider access. Narayanan closes with the push toward biomarker-guided, precision use and next-generation antibody designs.
Catalog record
| CREATOR | Kannan Badri Narayanan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 141 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |